CAN CSA C22.2 No. 60601-2-62-15: Comprehensive Guide to Safety and Performance Requirements for High Intensity Therapeutic Ultrasound Equipment

Understanding the Canadian adoption of IEC 60601-2-62 for therapeutic ultrasound devices

Scope and Application

CAN CSA C22.2 No. 60601-2-62-15, titled Medical Electrical Equipment – Part 2-62: Particular Requirements for the Basic Safety and Essential Performance of High Intensity Therapeutic Ultrasound (HITU) Equipment, is the Canadian adoption of IEC 60601-2-62:2010, with national deviations. This standard applies to medical electrical equipment used for non-invasive therapeutic ultrasound treatments, specifically equipment that generates high-intensity focused ultrasound (HIFU) or similar ultrasound fields intended to produce thermal or mechanical effects in biological tissues.

HITU equipment is used in a range of clinical applications including tumor ablation, treatment of uterine fibroids, and other soft tissue conditions. The standard provides essential safety and performance requirements for these devices under normal and single-fault conditions, ensuring that the equipment does not present unacceptable risks to patients, operators, or the environment.

Note: The standard excludes diagnostic ultrasound equipment (covered by other parts of IEC 60601 series) and equipment for extra-corporeal shockwave lithotripsy (ESWL). It specifically focuses on therapeutic devices where ultrasound intensity levels are sufficient to cause tissue alteration.

The scope includes all subsystems of the HITU equipment: the therapy applicator (transducer), the generator and control electronics, the cooling system (if integral), and the user interface. The standard also covers equipment intended to operate in conjunction with imaging guidance (ultrasound, MRI, or other modalities) that may be used for treatment planning and monitoring.

Technical Requirements and Key Clauses

CAN CSA C22.2 No. 60601-2-62-15 modifies and supplements the general requirements of the IEC 60601-1 collateral standards. Below is a summary of the key technical requirements drawn from the standard’s clauses:

Clause / Requirement Description Critical Limits / Thresholds
201.12 – Output accuracy Acoustic output power and intensity must be measured under defined conditions and must deviate by no more than ±20% from the set value at nominal operating conditions. ±20% of indicated power; ±1 dB for intensity
201.13 – Patient coupling verification The equipment must detect adequate acoustic coupling between the applicator and patient; if coupling is insufficient, therapy energy delivery must be interrupted. Coupling quality must be validated before and during delivery
201.14 – Applicator surface temperature Under normal use, the temperature of any part of the applicator contacting the patient must not exceed 41 °C. Under single-fault condition, the limit is 50 °C. 41 °C (normal); 50 °C (single-fault)
201.15 – Inadvertent output prevention The equipment must prevent accidental emission of therapeutic ultrasound unless all pre-conditions (e.g., coupling, positioning) are satisfied. A manual reset is required to restart treatment after an interruption. Hardware and software safeguards
201.16 – Protection against excessive output Maximum acoustic output must be limited by design to prevent uncontrolled heating or mechanical damage. Limits are based on thermal index (TI) and mechanical index (MI) scaled for therapy. TI ≤ 6.0; MI ≤ 1.0 (therapy safe limits, though application-specific)
201.17 – User interface and alarms All critical parameters (power, temperature, dose) must be displayed. Audible and visible alarms must be provided for predefined fault conditions. Alarm priority levels per IEC 60601-1-8
201.18 – Cleaning and disinfection The applicator and accessories must be capable of withstanding repeated cleaning and disinfection according to manufacturer’s instructions without degrading safety or performance. Test cycles: minimum 100 cleaning cycles
Important Consideration: The ±20% output tolerance is a minimum default; the manufacturer may specify tighter tolerances based on clinical necessity. However, any applied deviation must be justified and validated in the risk management file.

Additional requirements address electromagnetic compatibility (EMC) per CISPR 11 / IEC 60601-1-2, as well as electrical safety tests such as dielectric strength, leakage current, and protective earth bonding. The standard also places emphasis on software validation for any programmable subsystems, in accordance with IEC 62304.

Implementation and Compliance Considerations

To demonstrate compliance with CAN CSA C22.2 No. 60601-2-62-15, manufacturers must prepare a technical documentation package that includes:

  • A risk management process per ISO 14971, specifically identifying hazards related to thermal and mechanical bioeffects, coupling loss, and unintended output.
  • Detailed test reports for acoustic output measurements using a calibrated hydrophone or radiation force balance in a deionized water tank at 22 °C ± 2 °C.
  • Verification of coupling detection algorithms through simulated fault conditions (e.g., air gap, tissue-mimicking material with known acoustic impedance).
  • Temperature measurements at the applicator surface using thermocouples or infrared thermography under worst-case operating conditions.
  • Software hazard analysis and unit/integration tests for all safety-related functions (e.g., emergency stop, power ramping, alarm generation).
Compliance Pathway: For manufacturers already compliant with IEC 60601-2-62:2010, the Canadian adoption is largely harmonized. However, updates may be needed for national deviations, such as Canadian requirements for bilingual labeling (English and French) and specific references to the Canadian Electrical Code (CEC).

Certification to CAN CSA C22.2 No. 60601-2-62-15 is typically performed by a recognized testing laboratory accredited by the Standards Council of Canada (SCC), such as CSA Group or Intertek. The process includes both type testing and factory inspection for ongoing compliance. Manufacturers should also be aware that HITU equipment may be classified as a Class III or IV medical device under the Canadian Medical Devices Regulations (SOR/98-282), requiring submission of a medical device license application with evidence of conformity to this standard.

Critical Note: The standard includes a requirement (Clause 201.15.3) for a dedicated hardware-based safety relay that disconnects the high-voltage power supply within 100 ms of detecting a fault. Software-only interlocks are not acceptable. This must be demonstrated during the certification audit.

Practical Recommendations for Manufacturers

Based on common non-conformities observed during certification, the following areas deserve particular attention:

  • Coupling monitoring: Use multiple sensors (e.g., piezo elements, impedance monitoring) to provide redundancy; ensure that sensitivity is adequate for different patient anatomies and operating frequencies.
  • Thermal management: Design applicator cooling paths with fail-safe mechanisms (e.g., redundant pumps, thermal fuses) to maintain skin temperature within safe limits even if a cooling fan fails.
  • Output verification: Implement built-in test (BIT) routines that automatically verify acoustic output before each treatment session. Document the correlation between electrical power measured and acoustic output.
  • User interface and alarms: Follow the alarm prioritization in IEC 60601-1-8:2012; ensure that high-priority alarms (e.g., coupling loss, over-temperature) cannot be silenced or overridden inadvertently.

FAQs

Q: What is the relationship between CAN CSA C22.2 No. 60601-2-62-15 and IEC 60601-2-62:2010?
A: The Canadian standard is technically identical to IEC 60601-2-62:2010, with national modifications to address Canadian regulatory requirements (e.g., bilingual labeling, specific safety marking, and references to the Canadian Electrical Code). Manufacturers who comply with the IEC version can usually demonstrate compliance with the Canadian version after addressing these national deviations.
Q: Does the standard apply to MRI-guided focused ultrasound (MRgFUS) systems?
A: Yes, the standard covers all HITU equipment regardless of the imaging modality used for guidance. However, additional requirements from IEC 60601-2-33 (for MRI safety) also apply when the system is integrated with a magnetic resonance imager.
Q: What are the main testing challenges for HITU compliance?
A: Acoustic output measurement requires precise calibration and a controlled environment. The coupling detection test is also complex because it must simulate various conditions (skin contact, gel layer, accidental air pocket). Most manufacturers engage a specialized test house with experience in high-power ultrasound metrology.
Q: Are there any upcoming revisions to this standard?
A: IEC 60601-2-62:2019 (second edition) has been published internationally. As of 2026, Canada has not adopted the second edition; the 2015 edition (CAN CSA C22.2 No. 60601-2-62-15) remains current. It is advisable to monitor CSA Group announcements for updates.

The adoption of CAN CSA C22.2 No. 60601-2-62-15 ensures that HITU equipment marketed in Canada meets the highest safety and performance benchmarks. Manufacturers should integrate these requirements early in the design process to reduce compliance risk and streamline certification efforts.

© 2026 – This technical article is provided for informational purposes and does not constitute legal or certification advice. The latest official version of the standard should be consulted for compliance activities.

📥 Standard Documents Download

🔒
Please wait 10 seconds, the download links will appear after the ad loads

Leave a Reply

Your email address will not be published. Required fields are marked *